News Daily News Expert Consensus Advocates for Normalizing Pregnancy in Cath Labs L.A. McKeown December 08, 2022
News Daily News Interventional Cardiology Fellowship to Move to a Match for 2025 Yael L. Maxwell December 07, 2022
News Daily News FDA: Endologix AAA Grafts Get New Labeling That Addresses Endoleak Potential L.A. McKeown December 06, 2022
News Opinion Fellow Talk What Role Do Textbooks Play in Cardiology Training Today? Tushar Mishra, MD December 06, 2022
News Daily News Impella RP Mortality Rate No Longer a Concern, FDA Says Caitlin E. Cox December 05, 2022
News Features Does BEST-CLI Settle the Surgery vs Endovascular Question for CLTI? L.A. McKeown December 02, 2022
News Conference News PCR London Valves 2022 TAVI Dipped Worldwide in Early COVID-19 Waves, but That’s Not the Whole Story Shelley Wood November 30, 2022
News Daily News Many ESC Guideline Recommendations Out of Reach in Poorer Regions Michael O'Riordan November 29, 2022
News Daily News Less Occlusion, Hematomas With Distal Radial Access: Meta-analysis Michael O'Riordan November 22, 2022
News Daily News Exposure to Lead Linked to Risk of CVD Mortality: Strong Heart Study Michael O'Riordan November 18, 2022
News Conference News Paclitaxel Safety Concerns Wane as Hope Emerges for Newer PAD Devices L.A. McKeown November 18, 2022
News Daily News Many STEMI Patients Not Treated Within National Time Goals Michael O'Riordan November 15, 2022
News Conference News AHA 2022 Long-Awaited BEST-CLI Results Favor Surgery Over Endovascular Therapy in CLTI L.A. McKeown November 07, 2022
News Conference News AHA 2022 ISCHEMIA-EXTEND: So Far, Deaths Match for Invasive and Conservative Arms in Stable CAD Shelley Wood November 06, 2022
News Conference News AHA 2022 BRIGHT-4: Large, ‘Clean’ Trial Clarifies Bivalirudin Benefits in STEMI Shelley Wood November 06, 2022
News Conference News AHA 2022 High-Sensitivity Troponin Testing on the Rise in the US but Still Limited Michael O'Riordan November 04, 2022
News Conference News VIVA 2022 ‘Heartless’ Indifference Drives PAD/CLTI Amputations in Underserved Groups L.A. McKeown November 04, 2022
News Conference News VIVA 2022 TRANSCEND: Low-Dose DCB for PAD Still Looking Good at 2 Years L.A. McKeown November 03, 2022